海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- EFFICACITE DU TRAITEMENT PAR POMPE A INSULINE EXTERNE CHEZ LE DIABETIQUE DE TYPE 2 : ETUDE RANDOMISEE EN PARALLELE SUR 1 AN VERSUS MULTI-INJECTIONS
- diabète de type II MedDRA version: 9.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus
- France
- 2009-03-16
Authorised
- PRIMARY PREVENTION OF ATOPY AND ASTHMA WITH ALLERGEN SUBLINGUAL IMMUNOTHERAPY - Mite allergy prevention study (MAPS)
- Development of atopy br>MedDRA version: 12.1 Level: LLT Classification code 10019857 Term: Hereditary allergy
- United Kingdom
- 2010-03-17
Authorised
- CLINICAL STUDY OF APPRAISAL OF THE EFFECTIVENESS OF 1,25 (OH)2D3 (CALCITRIOL) TOWARDS PLACEBO IN THE DIABETES OF TYPE 1 OF RECENET INSORGENCE (IMDIAB XIII)
- GLICOMETABOLIC CONTROL AND ENDOGENOUS INSULIN SECRETION MedDRA version: 6.1 Level: PT Classification code 10012601
- Italy
- 2005-07-25
Authorised
- A Phase 1/2 Trial of SRA737 in Subjects with Advanced Cancer
- Patients with histologically or cytologically proven advanced solid tumours, refractory to conventional treatment, or for which no conventional therapy is considered appropriate by the Investigator. MedDRA version: 20.0 Level: LLT Classification code 10007050 Term: Cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- United Kingdom
- 2016-02-02
Authorised
- Treatment against viruses at the onset of type 1 diabetes
- Newly diagnosed Type 1 Diabetes diagnosed within the previous three weeks at time of screening. Female and male patients between the ages of 6 and 15 years will be recruited. MedDRA version: 19.1 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
- Norway, Sweden
- 2017-01-25
Authorised
- A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
- Lymphoid or myeloid neoplasm with 8p11 rearrangement known to lead to FGFR1 activation;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, France, Germany, Italy, Spain, Switzerland, United Kingdom, United States
- 2017-01-24
Authorised
- Control y seguimiento de pacientes infectados por VIH-1 en tratamiento antirretroviral y en programa de mantenimiento con metadona - Estudio Cometa
- VIH positivos en programa de mantenimiento con metadona
- Spain
- 2005-09-02
Authorised
- Ensayo clínico multicéntrico, aleatorizado, paralelo, doble ciego, para evaluar la eficacia y seguridad de eberconazol solución 1% frente a placebo en el tratamiento de las dermatofitosis
- Dermatofitosis Classification code 10012504
- Spain
- 2005-07-05
Authorised
- Mechanisms responsible for cardiac and skeletal muscle energetic impairment in type 1 diabetes
- Type 1 Diabetes Mellitus
- United Kingdom
- 2006-09-18
Authorised
- ESTUDIO DE LA INFLUENCIA DE LAS ESTATINAS EN LA REPLICACIÓN PLASMÁTICA DEL VIH EN PACIENTES CON INFECCION POR EL VIH-1 QUE INTERRUMPEN EL TRATAMIENTO ANTIRRETROVIRAL
- Patients HIV infected
- Spain
- 2006-07-10
